Canada’s Drug Agency recommends funding this drug for early-stage Alzheimer’s disease CTV NewsLondon researcher, families celebrate Alzheimer’s drug funding reversal London Free PressCanada’s Drug Agency recommends funding lecanemab for early-stage Alzheimer’s disease CityNews KitchenerCanada’s Drug Agency reverses course, now recommends public drug plans cover Alzheimer’s drug The Globe and MailHistoric Step for Alzheimer’s Care in Canada: CDA-AMC Recognizes Clinical Value of LEQEMBI® (lecanemab) and Recommends Public Coverage for Early Alzheimer’s Disease Newswire Canada
